Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group

Aliya N. Husain, Thomas V. Colby, Nelson G. Ordóǹez et al. · Archives of Pathology & Laboratory Medicine · 2017 · 612 citations · Full text

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group

Aliya N. Husain, Thomas V. Colby, Nelson G. Ordóǹez et al. · Archives of Pathology & Laboratory Medicine · 2012 · 462 citations

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Jörg Kleeff, Toshiyuki Ishiwata, Asli Kumbasar et al. · Journal of Clinical Investigation · 1998 · 364 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

Justin A. Bishop, Rajni Sharma, Peter B. Illei · Human Pathology · 2009 · 330 citations

Tumor Biology, Endocrine-related Cancer, Oncogenic Agent +8

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group

Aliya N. Husain, Thomas V. Colby, Nelson G. Ordóǹez et al. · Archives of Pathology & Laboratory Medicine · 2009 · 292 citations